Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495716 · ClinicalTrials.gov registry record · Phase 4
Effect of HSV-2 Suppressive Therapy on Sexual Behavior
A Phase 4 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
NCT00495716 is a Phase 4 study that was terminated before completion, run by University of Washington. The registered enrollment target is 72 participants.
The verdict
NCT00495716, a Phase 4 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to determine what effect suppressive therapy has on sexual behavior and quality of life among persons with genital herpes (HSV) who have multiple sex partners. Study terminated; investigator relocated and study funding ended. Results were never analyzed because data were not collected.
Interventions
- DRUG acyclovir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00495716
The ClinicalTrials.gov registry entry for NCT00495716 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which acyclovir is the first listed.
NCT00495716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00495716 about?
NCT00495716 is a clinical study titled "Effect of HSV-2 Suppressive Therapy on Sexual Behavior". The purpose of this study is to determine what effect suppressive therapy has on sexual behavior and quality of life among persons with genital herpes (HSV) who have multiple sex partners. Study terminated; investigator relocated and study funding ended. Results were never analyzed because data wer...
What is the current status of trial NCT00495716?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2008-01. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00495716?
The interventions under investigation include: acyclovir (DRUG).
Who is sponsoring clinical trial NCT00495716?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.